NCT05209347

Brief Summary

The proposed study evaluates the effect of carbon fiber brace design on forces across the ankle. Research suggests that ankle arthritis develops following ankle fracture due, in part, to elevated forces on the cartilage. It is expected that carbon fiber braces can reduce forces in the ankle joint thereby reducing the risk of developing arthritis following injury. In this study, carbon fiber braces will be tested to determine how they influence the forces acting on the ankle cartilage. The proposed study will provide evidence that can be used by clinicians and researchers to design carbon fiber braces to effectively reduce forces on ankle cartilage.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 26, 2022

Completed
2.8 years until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 15, 2026

Status Verified

December 1, 2023

Enrollment Period

1 year

First QC Date

January 12, 2022

Last Update Submit

January 13, 2026

Conditions

Keywords

Carbon FiberGait AnalysisAnkle Foot OrthosisArthritisBiomechanicsAnkleAdult

Outcome Measures

Primary Outcomes (11)

  • Joint Contact Stress Exposure (Model estimated)

    Joint contact stress exposure (MPA-s/gait cycle) will be estimated using a participant specific musculoskeletal model.

    Baseline

  • Peak Plantar Force (total foot)

    Plantar forces (N) will be measured across the forefoot (100% of sensor) as participants walk without a CDO and with each CDO.

    Baseline

  • Plantar Force Impulse (total foot)

    Plantar force impulse (Ns) across the forefoot (100% of sensor) will be calculated using the integral of the force over the stance phase as participants walk without a CDO and with each CDO.

    Baseline

  • Peak Plantar Force (forefoot)

    Plantar forces (N) will be measured across the forefoot (distal 40% of sensor) as participants walk without a CDO and with each CDO.

    Baseline

  • Plantar Force Impulse (forefoot)

    Plantar force impulse (Ns) across the forefoot (distal 40% of sensor) will be calculated using the integral of the force over the stance phase as participants walk without a CDO and with each CDO.

    Baseline

  • Peak Plantar Force (midfoot)

    Plantar forces (N) will be measured across the forefoot (middle 30% of sensor) as participants walk without a CDO and with each CDO.

    Baseline

  • Plantar Force Impulse (midfoot)

    Plantar force impulse (Ns) across the forefoot (middle 30% of sensor) will be calculated using the integral of the force over the stance phase as participants walk without a CDO and with each CDO.

    Baseline

  • Peak Plantar Force (hindfoot)

    Plantar forces (N) will be measured across the forefoot (proximal 30% of sensor) as participants walk without a CDO and with each CDO.

    Baseline

  • Plantar Force Impulse (hindfoot)

    Plantar force impulse (Ns) across the forefoot (proximal 30% of sensor) will be calculated using the integral of the force over the stance phase as participants walk without a CDO and with each CDO.

    Baseline

  • Numerical Pain Rating Scale

    Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable.

    Baseline

  • Participant Device Preference

    The participant will rank order their preference for their standard of care device (if applicable), NoCDO, CDO-A, CDO-B on a questionnaire.

    Baseline

Secondary Outcomes (8)

  • Four Square Step Test (4SST)

    Baseline

  • Sit to Stand 5 Times (STS5)

    Baseline

  • Ankle Range of Motion

    Baseline

  • Peak Ankle Moment

    Baseline

  • Peak Ankle Power

    Baseline

  • +3 more secondary outcomes

Other Outcomes (8)

  • Semi-Structured Interview

    Baseline

  • Center of pressure velocity timing

    Baseline

  • Center of pressure velocity magnitude

    Baseline

  • +5 more other outcomes

Study Arms (3)

NoCDO

NO INTERVENTION

Participants will be evaluated without a CDO

CDO-A

EXPERIMENTAL

The first study CDO will be designated CDO-A

Device: Carbon Fiber Custom Dynamic Orthosis (CDO)

CDO-B

EXPERIMENTAL

The second study CDO will be designated CDO-B

Device: Carbon Fiber Custom Dynamic Orthosis (CDO)

Interventions

The carbon fiber custom dynamic orthosis will consist of a semi-rigid foot plate, a posterior carbon fiber strut, and a proximal cuff below the knee.

Also known as: Ankle Foot Orthosis (AFO)
CDO-ACDO-B

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 18 and 65
  • Sustained unilateral fracture of the tibial pilon
  • The fracture has completely healed
  • Ability to walk 50 feet without use of an assistive device (cane, crutch, etc.)
  • Ability to walk at a slow to moderate pace
  • Shoe size between women's 8 and 13.5 or men's 6.5 and 12
  • Ability to read and write in English and provide written informed consent
  • Individuals with elevated contact stress according to model generated using standing CT images (will be answered after completing visit one)

You may not qualify if:

  • Pain \> 6/10 while walking
  • Increase in pain during testing of 3/10 or greater
  • Neurologic, musculoskeletal (including bilateral fractures) or other condition limiting function of the contralateral extremity
  • Medical or psychological condition that would preclude functional testing (ex. moderate or severe brain injury, stroke, heart disease)
  • Wounds to the calf that would prevent CDO fitting
  • Fractures secondary to neuropathy or severe osteopenia
  • Classification as non-ambulatory
  • Previous fractures near the tibial pilon on the involved limb
  • Surgery on involved limb anticipated in the next 6 months
  • Requirement of a knee stabilizing device (i.e. KAFO, KO…) to perform daily activities
  • Visual or hearing impairments that limit walking ability or limit the ability to comply with instructions given during testing
  • BMI greater than 40
  • Pregnancy- Per participant self-report. Due to the expected small number of pregnant individuals and resulting inability to account for its effect on resulting outcomes, participants will be withdrawn from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa

Iowa City, Iowa, 52241, United States

Location

MeSH Terms

Conditions

Ankle FracturesArthritis

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesAnkle InjuriesLeg InjuriesJoint DiseasesMusculoskeletal Diseases

Study Officials

  • Jason M Wilken, PT, PhD

    University of Iowa

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be blinded to the different CDO designs and will only be introduced to each device as CDO-A or CDO-B.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: All participants will be cast and fit with two CDOs. Each CDO will be labeled as CDO-A or CDO-B. Participants will be randomly assigned to one of two CDO testing sequences (AB, BA) to prevent testing order from influencing study results.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Collaborative Research and Development, Associate Professor

Study Record Dates

First Submitted

January 12, 2022

First Posted

January 26, 2022

Study Start

December 1, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

January 15, 2026

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations